Enhancing the Anti-Cancer Immune Response by Combining Radiotherapy and Immunotherapy

肺癌是澳大利亚癌症相关死亡的最大原因。最近，免疫疗法通过释放人体自身的防御来对抗肺癌，显示出了希望。我的目标是通过高精度立体定向消融体放疗（SABR）“启动”免疫反应，最大限度地提高抗pd -1免疫治疗的效果。通过完成临床试验和生物学研究，我希望能改善肺癌患者的治疗效果。

Lung cancer is the biggest cause of cancer related death in Australia. Recently, immune therapies have shown promise by unlocking the body’s own defenses to fight against lung cancer. I aim to maximise the effect of the anti-PD-1 immune therapy by ‘kick-starting’ the immune response with high-precision stereotactic ablative body radiotherapy (SABR). By completing clinical trials and biological research into the combination of therapies I hope to improve outcomes for patients with lung cancer.